» Articles » PMID: 30246808

Potts Shunt to Be Preferred Above Atrial Septostomy in Pediatric Pulmonary Arterial Hypertension Patients: A Modeling Study

Overview
Journal Front Physiol
Date 2018 Sep 25
PMID 30246808
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

To quantitatively evaluate the basic pathophysiological process involved in the creation of Eisenmenger syndrome in pediatric pulmonary arterial hypertension (PAH) patients by either atrial septostomy (AS) or Potts shunt (PS) as well as to predict the effects of AS or PS in future PAH patients. The multi-scale lumped parameter CircAdapt model of the cardiovascular system was used to investigate the effects of AS and PS on cardiovascular hemodynamics and mechanics, as well as on oxygen saturation in moderate to severe PAH. The reference simulation, with cardiac output set to 2.1 l/min and mean systemic pressure to 61 mmHg, was used to create a compensated moderate PAH simulation with mPAP 50 mmHg. Thereupon we created a range of decompensated PAH simulations in which mPAP was stepwise increased from 50 to 80 mmHg. Then we simulated for each level of mPAP the acute effects of either PS or AS with connection diameters ranging between 0-16 mm. For any mPAP level, the effect on shunt flow size is much larger for the PS than for AS. Whereas right ventricular pump work in PS is mainly dependent on mPAP, in AS it depends on both mPAP and the size of the defect. The effects on total cardiac pump work were similar for PS and AS. As expected, PS resulted in a drastic decrease of lower body oxygen saturation, whereas in AS both the upper and lower body oxygen saturation decreased, though not as drastically as in PS. Our simulations support the opinion that a PS can transfer suprasystemic PAH to an Eisenmenger physiology associated with a right-to-left shunt at the arterial level. Contrary to the current opinion that PS in PAH will decompress and unload the right ventricle, we show that while a PS does lead to a decrease in mPAP toward mean systemic arterial pressure, it does not unload the right ventricle because it mainly diverts flow from the pulmonary arterial system toward the lower body systemic arteries.

Citing Articles

Reversed Potts Shunt Outcome in Suprasystemic Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.

Mendel B, Christianto C, Angellia P, Holiyono I, Prakoso R, Siagian S Curr Cardiol Rev. 2022; 18(6):e090522204486.

PMID: 35538823 PMC: 9893152. DOI: 10.2174/1573403X18666220509203335.


Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study.

Pant S, Sizarov A, Knepper A, Gossard G, Noferi A, Boudjemline Y Biomech Model Mechanobiol. 2022; 21(2):471-511.

PMID: 35000016 PMC: 8940869. DOI: 10.1007/s10237-021-01545-2.


Heart failure therapy based on interventricular mechanics and cardio-vascular communications.

Schranz D, Akintuerk H, Esmaeili A, Latus H, Apitz C Cardiovasc Diagn Ther. 2021; 11(4):1080-1088.

PMID: 34527534 PMC: 8410498. DOI: 10.21037/cdt-20-347.


Successful Management of an Infant with Atypical Presentation of Alveolar Capillary Dysplasia with Misalignment of the Pulmonary Veins.

Neuhauser C, Kreymborg K, Muller C, Khalil M, Jux C, Galambos C J Pediatr Intensive Care. 2021; 10(3):228-231.

PMID: 34395042 PMC: 8354349. DOI: 10.1055/s-0040-1713437.


Interventional and Surgical Treatments for Pulmonary Arterial Hypertension.

Stacel T, Latos M, Urlik M, Necki M, Antonczyk R, Hrapkowicz T J Clin Med. 2021; 10(15).

PMID: 34362109 PMC: 8348951. DOI: 10.3390/jcm10153326.


References
1.
Sandoval J, Gaspar J, Pulido T, Bautista E, Zeballos M, Palomar A . Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998; 32(2):297-304. DOI: 10.1016/s0735-1097(98)00238-1. View

2.
Galie N, Hoeper M, Humbert M, Torbicki A, Vachiery J, Barbera J . Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the.... Eur Heart J. 2009; 30(20):2493-537. DOI: 10.1093/eurheartj/ehp297. View

3.
Baruteau A, Belli E, Boudjemline Y, Laux D, Levy M, Simonneau G . Palliative Potts shunt for the treatment of children with drug-refractory pulmonary arterial hypertension: updated data from the first 24 patients. Eur J Cardiothorac Surg. 2014; 47(3):e105-10. DOI: 10.1093/ejcts/ezu445. View

4.
Kurzyna M, Dabrowski M, Bielecki D, Fijalkowska A, Pruszczyk P, Opolski G . Atrial septostomy in treatment of end-stage right heart failure in patients with pulmonary hypertension. Chest. 2007; 131(4):977-83. DOI: 10.1378/chest.06-1227. View

5.
Boudjemline Y, Patel M, Malekzadeh-Milani S, Szezepanski I, Levy M, Bonnet D . Patent ductus arteriosus stenting (transcatheter Potts shunt) for palliation of suprasystemic pulmonary arterial hypertension: a case series. Circ Cardiovasc Interv. 2013; 6(2):e18-20. DOI: 10.1161/CIRCINTERVENTIONS.112.000091. View